- GALT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Galectin Therapeutics (GALT) S-3Shelf registration
Filed: 31 Dec 03, 12:00am
Exhibit 23.3
INDEPENDENT AUDITORS’ CONSENT
We consent to the incorporation by reference in this Registration Statement of Pro-Pharmaceuticals, Inc. (the “Company”) on Form S-3 of our report (which expresses an unqualified opinion) dated April 10, 2002 with respect to the financial statements of the Company, which appears in the Company’s Annual Report on Form 10-KSB for the year ended December 31, 2002 and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ SCILLIA DOWLING & NATARELLI LLC
Scillia Dowling & Natarelli LLC
Hartford, CT
December 30, 2003
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.